BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10130682)

  • 1. Relationship between practice guidelines, formulary management, and pharmacoeconomic studies.
    Schrogie JJ; Nash DB
    Top Hosp Pharm Manage; 1994 Jan; 13(4):38-46. PubMed ID: 10130682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of pharmacoeconomic data in formulary selection.
    Hatoum HT; Freeman RA
    Top Hosp Pharm Manage; 1994 Jan; 13(4):47-53. PubMed ID: 10130683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomics and formulary decision making.
    Sanchez LA
    Pharmacoeconomics; 1996; 9 Suppl 1():16-25. PubMed ID: 10160112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and misuse of pharmacoeconomic terms: a definitions primer.
    Sanchez LA; Lee J
    Top Hosp Pharm Manage; 1994 Jan; 13(4):11-22. PubMed ID: 10184005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.
    Lipsy RJ
    Pharmacoeconomics; 1992 Apr; 1(4):265-81. PubMed ID: 10147017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research.
    Kozma CM; Reeder CE; Schulz RM
    Clin Ther; 1993; 15(6):1121-32; discussion 1120. PubMed ID: 8111809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacy benefit management: enhancing the applicability of pharmacoeconomics for optimal decision making.
    Mullins CD; Wang J
    Pharmacoeconomics; 2002; 20(1):9-21. PubMed ID: 11817989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoeconomic series: Part 3. Applying pharmacoeconomic and quality-of-life measures to the formulary management process.
    Skaer TL
    Hosp Formul; 1993 Jun; 28(6):577-84. PubMed ID: 10126586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporating pharmacoeconomic principles into hospital pharmacy practice.
    Gouveia WA; Bungay KM
    Top Hosp Pharm Manage; 1994 Jan; 13(4):31-7. PubMed ID: 10130681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoeconomic factors in the treatment of acute hypertension.
    Shulkin DJ
    Hosp Formul; 1994 Aug; 29 Suppl 2():S15-20. PubMed ID: 10135742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoeconomics: a managed care perspective.
    Clouse JC
    Top Hosp Pharm Manage; 1994 Jan; 13(4):54-9. PubMed ID: 10130684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The military health services system model for pharmacoeconomic decision making.
    Ries AJ; Potyk RP; Brier KL; Miller MR; Tornow JJ; Weber MP; Finder SF; Reeves CS
    Med Interface; 1995 May; 8(5):132-7. PubMed ID: 10142786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of pharmacoeconomic data in making hospital formulary decisions.
    Odedina FT; Sullivan J; Nash R; Clemmons CD
    Am J Health Syst Pharm; 2002 Aug; 59(15):1441-4. PubMed ID: 12166044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of pharmacoeconomics to formulary decision making in managed care organizations.
    Suh DC; Okpara IR; Agnese WB; Toscani M
    Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence of pharmacoeconomic studies to national guidelines in the Netherlands.
    Atthobari J; Bos JM; Boersma C; Brouwers JR; de Jong-van den Berg LT; Postma MJ
    Pharm World Sci; 2005 Oct; 27(5):364-70. PubMed ID: 16341742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoeconomics and the formulary decision-making process.
    Bakst A
    Hosp Formul; 1995 Jan; 30(1):42-50. PubMed ID: 10172201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to develop a proactive formulary system.
    Crane VS; Gonzalez ER; Hull BL
    Hosp Formul; 1994 Oct; 29(10):700-2, 704-8, 710. PubMed ID: 10137847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of a clinical pharmacology consult service as a formulary management tool.
    Albertson T; Musallam N; Tharratt S; Romac D; Foulke G; Mowers R; Panecek E
    Hosp Formul; 1993 Aug; 28(8):699-702, 707. PubMed ID: 10127748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the role of bias in pharmacoeconomic studies.
    Joish VN
    Manag Care Interface; 2001 Aug; 14(8):57-60. PubMed ID: 11517839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational formulary decision making: is drug classification rational?
    Berger ML
    Value Health; 2003; 6(2):175-6. PubMed ID: 12641868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.